Ex-Immunomedics Brass Must Face Del. Suit Over $250M Deal
A Delaware vice chancellor on Wednesday said enough evidence has been shown to infer four former directors of biotechnology firm Immunomedics Inc. possibly acted in bad faith when they approved a...To view the full article, register now.
Already a subscriber? Click here to view full article